RVLP Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 Oct 2023 @ 16:00):

Stats
Today's Volume	63.96M
Average Volume	24.42M
Market Cap	3.14M
EPS	$0 ( 2024-03-18 )
Next earnings date	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0397
ATR14	$0.0230 (500.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-19	Harsaul Foundation	Sell	9 363 760	Ordinary Shares
2023-10-20	Harsaul Foundation	Sell	4 758 899	Ordinary Shares
2023-10-19	Altchem Ltd	Sell	9 363 760	Ordinary Shares
2023-10-20	Altchem Ltd	Sell	4 758 899	Ordinary Shares
2023-10-18	Harsaul Foundation	Sell	3 421 537	Ordinary Shares

INSIDER POWER
-77.50
Last 95 transactions
Buy: 43 304 967 \| Sell: 77 056 281

Volume Correlation

Long: -0.31 (neutral)

Short: -0.42 (neutral)

Signal:(32.959) Neutral

RVL Pharmaceuticals plc Correlation

10 Most Positive Correlations
RPID	0.919
SLNH	0.916
GROM	0.914
WISA	0.913
TIL	0.909
SWVL	0.908
PAIC	0.904
TOPS	0.9
MDVL	0.899
QLGN	0.899

10 Most Negative Correlations
NETE	-0.931
HZNP	-0.907
SHSP	-0.906
CHNGU	-0.905
MNKD	-0.902
BOCH	-0.897
LRFC	-0.886
NWFL	-0.884
OBAS	-0.883
JOUT	-0.882

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

RVL Pharmaceuticals plc Correlation - Currency/Commodity

-0.75
( moderate negative )

-0.66
( moderate negative )

0.00
( neutral )

-0.75
( moderate negative )

-0.28
( neutral )

0.46
( neutral )

RVL Pharmaceuticals plc Financials

Annual	2022
Revenue:	$49.72M
Gross Profit:	$40.27M (80.98 %)
EPS:	$-0.580

FY	2022
Revenue:	$49.72M
Gross Profit:	$40.27M (80.98 %)
EPS:	$-0.580

FY	2021
Revenue:	$17.50M
Gross Profit:	$13.88M (79.33 %)
EPS:	$-0.960

FY	2020
Revenue:	$177.88M
Gross Profit:	$103.40M (58.13 %)
EPS:	$-1.310

Financial Reports:

No articles found.

RVL Pharmaceuticals plc

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.